Este estudo demonstrou que a luz azul possui ação antibacteriana em todos os protocolos in vitro testados, mostrando percentuais de inibição acima de 90%, indicando o uso de aplicação da fotoemissão em protocolos nos quais o agente infeccioso esteja em meio líquido rico em nutrientes como forma de otimizar testes de maior complexidade subsequentes. O teste de resistência mostrou que a luz azul pode induzir resistência em diferentes graus dependendo da bactéria analisada, sendo que entre as espécies estudadas a bactéria Escherichia coli mostrou a maior capacidade de desenvolver resistência.
REFERÊNCIAS
1 - SCHWARZ S, LOEFFLER A, KADLEC K. Bacterial resistance to antimicrobial agents and its impact on veterinary and human medicine. Vet Dermatol. 2017;28:82- e19.
2 - BUMAH VV, MASSON-MEYERS DS, CASHIN SE, ENWEMEKA CS.
Wavelength and bacterial density influence the bactericidal effect of blue light on methicillin-resistant Staphylococcus aureus (MRSA). Photomed Laser Surg.
2013;31(11):547-53.
3 - DAI T, GUPTA A, MURRAY CK, VRAHAS MS, TEGOS GP, HAMBLIN MR.
Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori and beyond?. Drug Resist Updat 2012;15:223-236.
4 - KHAN HA, BAIG FK, MEHBOOB R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478-482.
5 - CHAMBERS HF, DELEO FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7(9):629-641.
6 - LOUREIRO RJ, ROQUE F, RODRIGUES AT, HERDEIRO MT, RAMALHEIRA E. O uso de antibióticos e as resistências bacterianas: breves notas sobre a sua evolução.
Rev Port Saúde Pública. 2016;34(1):77-84.
7 - LUPKE KH, SUDA KJ, BOUCHER H, RUSSO RL, BONNEY MW, HUNT TD, MOHR JF. Past, present and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline and societal implications. Pharmacotherapy.
2017;37(1):71-84.
8 - ENWEMEKA CS, WILLIAMS D, ENWEMEKA SK, HOLLOSI S, YENS D. Blue 470-nm light kills methicillin-resistant Staphylococcus aureus (MRSA) in vitro.
Photomed Laser Surg 2009;27(2):221-6.
9 - World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed [Internet]. Geneva: World Health Organization; 2017.
Available from: http://www.who.int/mediacentre/news/releases/2017/bacteria- antibiotics-needed/en/
10 - SYDNOR ERM, PERL TM. Hospital epidemiology and infection control in acute- care settings. Clin Microbiol Rev. 2011;24(1):141-173.
11 - LOPES LKO, BRITO RMM, LIMA MCG, SANTOS DCL, LOPES LKO.
Epidemiologia das infecções relacionadas à assistência à saúde em unidades de terapia intensiva pediátricas do estado de Goiás, 2016. Journal of Infection Control. 2018;7(2).
12 - FENG W, SUN F, WANG Q, XIONG W, QIU X, DAI X, XIA P. Epidemiology and resistance characteristics of Pseudomonas aeruginosa isolates from the respiratory department of a hospital in China. J Glob Antimicrob Resist. 2017;8:142-147.
13 - ABBAS M, AGHAYEV E, TROILLET N, EISENRING MC, KUSTER SP, WIDMER AF, HARBATH S. Temporal trends and epidemiology of Staphylococcus aureus surgical site infection in the Swiss surveillance network: a cohort study. J Hosp Infect. 2018;98(2):118-126.
14 - FERNANDES MR, MOURA Q, SARTORI L, SILVA KC, CUNHA MP, ESPOSITO F, LOPES R, OTUTUMI LK, GONÇALVES DD, DROPA M, MATTÉ MH, MONTE DF, LANDGRAF M, FRANCISCO GR, BUENO MF, GARVIA DO, KNÖBL T, MORENO AM, LINCOPAN N. Silent dissemination of colistin-resistant Escherichia coli in South America could contribute to the global spread of the mcr-1 gene. Euro Surveill. 2016;21(17).
15 - FERNANDES MR, MCCULLOCH JA, VIANELLO MA, MOURA Q, PÉREZ- CHAPARRO PJ, ESPOSITO F, SARTORI L, DROPA M, MATTÉ MH, LIRA DPA, MAMIZUKA EM, LINCOPAN N. First report of the globally disseminater Incx4 plasmid carrying the mcr-1 gene in a colistin-resistant Escherichia coli ST101 isolated from a human infection in Brazil. Antimicrob Agents Chemother. 2016;60(10):6415-7.
16 - BUMAH VV, MASSON-MEYERS DS, CASHIN S, ENWEMEKA CS.
Optimization of the antimicrobial effect of blue light on methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med. 2015;47:266-272.
17 - DE SOUSA NT, SANTOS MF, GOMES RC, BRANDINO HE, MARTINEZ R, DE JESUS GUIRRO RR. Blue laser inhibits bacterial growth of Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. Photomed Laser Surg. 2015;33(5):278- 282.
18 - TRABULSI LR, ALTERTHUM F. Microbiologia. 4ª Ed. São Paulo: Atheneu, 2004.
19 - MONACO M, ARAUJO FP, CRUCIANI M, COCCIA EM, PANTOSTI A.
Worldwide epidemiology and antibiotic resistance of Staphylococcus aureus. Curr Top Microbiol Immunol. 2017;409:21-56
20 - RANJAN KP, RANJAN N, GANDHI S. Surgical site infections with special reference to methicillin resistant Staphylococcus aureus: experience from a tertiary care referral hospital in North India. Int J Res Med Sci. 2013;1(2):108-111.
21 - MARTINS MA, FRANCA E, MATOS JC, GOULART EMA. Vigilância pós-alta das infecções de sítio cirúrgico em crianças e adolescentes em um hospital universitário de Belo Horizonte, Minas Gerais, Brasil. Cad Saúde Pública 2008;24(5):1033-1041.
22 - SILVA MCC, PACHECO JS, FURTADO FVS, MATOS FILHO JC, DAMASCENO AKC. Epidemiologia das infecções em queimaduras no nordeste do Brasil. Rev Eletr Enf 2009;11(2):390-394.
23 - OLIVEIRA AC, KOVNER CT, SILVA RS. Infecção hospitalar em unidade de tratamento intensivo de um hospital universitário brasileiro. Rev Latino-Am Enfermagem 2010;18(2):97-104.
24 - ERCOLE FF, CHIANCA TCM, DUARTE D, STARLING CEF, CARNEIRO M.
Infecção de sítio cirúrgico em pacientes submetidos a cirurgias ortopédicas: o índice de risco NNIS e predição de risco. Rev Latino-Am Enfermagem 2011;19(2).
25 - GUIMARAES AC, DONALISIO MR, SANTIAGO THR, FREIRE JB. Óbitos associados à infecção hospitalar, ocorridos em um hospital geral de Sumaré-SP, Brasil.
Rev Bras Enferm 2011;64(5):864-869.
26 - BATISTA TF, RODRIGUES MCS. Vigilância de infecção de sítio cirúrgico pós- alta hospitalar em hospital de ensino do Distrito Federal, Brasil: estudo descritivo retrospectivo no período 2005-2010. Epidemiol Serv Saúde 2012;21(2):253-264.
27 - FALKINHAM JO, HILBORN ED, ARDUINO MJ, PRUDEN A, EDWARDS MA.
Epidemiology and ecology of opportunistic premise plumbing pathogens: Legionella pneumophila, Mycobacterium avium and Pseudomonas aeruginosa. Environ Health Perspect. 2015;123(8):749-758.
28 - OLIVER A, MULET X, LÓPEZ-CAUSAPÉ C, JUAN C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21-22:41-59.
29 - CHANEY SB, GANESH K, MATHEW-STEINER S, ROY S, SEN CK, WOZNIAK DJ. Histopathological comparisons of Staphylococcus aureus and Pseudomonas aeruginosa experimental infected porcine burn wounds. Wound Repair Regen. 2017;25(3):541-549
30 - BRITT NS, RITCHIE DJ, KOLLEF MH, BURNHAM CAD, DURKIN MJ, HAMPTON NB, MICEK ST. Importance of site of infection and antibiotic selection in
the treatment of carbapenem-resistant Pseudomonas aeruginosa sepsis. Antimicrob Agents Chemother. 2018;62(4).
31 - ALVES PM, AL-BADI E, WITHYCOMBE C, JONES PM, PURDY KJ, MADDOCKS SE. Interaction between Staphylococcus aureus and Pseudomonas aeruginosa is beneficial for colonisation and pathogenicity in a mixed-biofilm. Pathog Dis. 2018;76(1).
32 - PORSE A, GUMPERT H, KUBICEK-SUTHERLAND JZ, KARAMI N, ADLERBERTH I, WOLD AE, ANDERSSON DI, SOMMER MOA. Genome dynamics of Escherichia coli during antibiotic treatment: transfer, loss, and persistence of genetic elements in situ of the infant gut. Front Cell Infect Microbiol. 2017;7(126).
33 - UKAH UV, GLASS M, AVERY B, DAIGNAULT D, MULVEY MR, REID- SMITH RJ, PARMLEY EJ, PORTT A, BOERLIN P, MANGES AR. Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community- acquired urinary tract infections. Epidemiol Infect. 2018;146(1):46-57.
34 - ABERNETHY J, GUY R, SHERIDAN EA, HOPKINS S, KIERNAN M, WILCOX MH, JOHNSON AP, HOPE R. Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme. J Hosp Infect. 2017;95(4):365-375.
35 - CHAKRABORTY A, SARALAYA V, ADHIKARI P, SHENOY S. Virulence property, phylogenetic background, and resistance pattern of Escherichia coli isolates from wound infections. CHRISMED J Health Res. 2017;4(4):248-252.
36 - HADIS MA, ZAINAL SA, HOLDER MJ, CARROLL JD, COOPER PR, MILWARD MR, PALIN WM. The dark art of light measurement: accurate radiometry for low-level light therapy. Lasers Med Sci. 2016;31:789–809.
37 - FARIVAR S, MALEKSHAHABI T, SHIARI R. Biological effects of low level laser therapy. J Lasers Med Sci. 2014;5(2):58-62.
38 - ÖZBERK SS, GÜNDOGAR H, SENYURT SZ, ERCIVAS K. Adjunct use of low- level laser therapy on the tratment of necrotizing ulcerativa gengivitis: a case report. J Lasers Med Sci. 2018;9(1):73-75.
39 - PRIBAC V, TODEA C, DUMA VF. Low-level laser therapy (LLLT) for periodontal pockets: A review. In Sixth International Conference on Lasers in Medicine (Vol. 9670, p. 96700K). International Society for Optics and Photonics.
40 - KUFFLER DP. Improving the ability to eliminate wounds and pressure ulcers.
Wound Rep Reg. 2015;23:312–317.
41 - KURACH LM, STANLEY BJ, GAZZOLA KM, FRITZ MC, STEFICEK BA, HAUPTMAN JG, SEYMOUR JK. The effect of low-level laser therapy on the healing of open wounds in dogs. Vet Surg. 2015;44:988–996.
42 - NASIRIAN N, NASIRIAN A. Effect of low level (infra red) laser therapy on the surgical wound healing in hamster. Iran J Pathol. 2012;7(4):236-240.
43 - PARK JT, HONG KS. Effect of light-emitting-diode irradiation on the proliferation and migration in human gingival fibroblasts. J Tissue Eng Regen Med. 2015;12(1):37- 42.
44 - PEREIRA PR, PAULA JB, CIELINSKI J, PILONETTO M, VON BAHTEN LC.
Effects of low intensity laser in in vitro bacterial culture and in vivo infected wounds.
Rev Col Bras Cir. 2014;41(1):49-55.
45 - ANDRAUS RAC, MAIA LP, SANTOS JOM, MESQUITA AR, SANTOS TG, BRAOIOS A, PRADO RP. Analysis of low level laser therapy in vitro cultures of bacteria and fungi. MTP&RehabJournal. 2015;13(304).
46 - KIM S, KIM J, LIM W, JEON S, KIM O, KOH JT, KIM CS, CHOI H, KIM O. In vitro bactericidal effects of 625, 525 and 425 nm wavelength (red, green and blue) light- emitting diode irradiation. Photomed Laser Surg 2013;31(11):554-562
47 - GOMES TF, PEDROSA MM, TOLEDO ACL, ARNONI VW, MONTEIRO MS, PIAI DC, SYLVESTRE SHZ, FERREIRA B. Bactericide effect of methylene blue associated with low-level laser therapy in Escherichia coli bacteria isolated from pressure ulcers. Lasers Med Sci. 2018.
48 - MARCIANO RS, SERGIO LPS, POLIGNANO GAC, PRESTA GA, GUIMARÃES OR, GELLER M, PAOLI S, PAOLI F, FONSECA AS. Laser for treatment of aphthous ulcers on bacteria cultures and DNA. Photochem Photobiol Sci.
2012;11:1476-83.
49 - SEYEDMOUSAVI S, HASHEMI SJ, REZAIE S, FATEH M, DJACID GE, ZIBAFAR E, MORSALI F, ZAND N, ALINAGHIZADEH M, ATAIE-FASHTAMI L.
Effects of low-level laser irradiation on the pathogenicity of Candida albicans: in vitro and in vivo study. Photomed Laser Surg. 2014;32(6):322-329.
50 - BARBOZA LL, CAMPOS VMA, MAGALHÃES LAG, PAOLI F, FONSECA AS. Low-intensity red and infrared laser effects at high fluences on Escherichia coli cultures. Braz J Med Biol Res. 2015:48(10):945–952.
51 - NUSSBAUM EL, LILGE L, MAZZULLI T. Effects of 810 nm laser irradiation on in vitro growth of bacteria: comparison of continuous wave and frequency modulated light. Lasers Surg Med. 2002;31:343-51.
52 - LEE SYC, SEONG IW, KIM JS, CHEON KA, GU SH, KIM HH, PARK KH.
Enhancement of cutaneous immune response to bacterial infection after low-level light therapy with 1072 nm infrared light: A preliminary study. J Photochem Photobiol B.
2011;105:175-82.
53 - COSTA AF, ASSIS JCL. In vitro assessment of the bactericidal effect of low- power arsenium-gallium (AsGa) laser treatment. An Bras Dermatol. 2012;87(4):654-6.
54 - LEI X, LIU B, HUANG Z, WU J. A clinical study of photodynamic therapy for chronic skin ulcers in lower limbs infected with Pseudomonas aeruginosa. Arch Dermatol Res. 2015;307(1):49-55.
55 - CRETELLA G, LAJOLO C, CASTAGNOLA R, SOMMA F, INCHINGOLO MT, MARIGO L. The effect of diode laser on planktonic Enterococcus faecalis in infected root canals in an ex vivo model. Photomed Laser Surg. 2017;35(4):190-194.
56 - SCHIFFNER U, CACHOVAN G, BASTIAN J, SCULEAN A, EICK S. In vitro activity of photoactivated disinfection using a diode laser in infected root canals. Acta Odontol Scand. 2014;72(8):673-680.
57 - SEBRÃO CCN, BEZERRA JUNIOR AG, FRANÇA PHC, FERREIRA LE, WESTPHALEN VPD. Comparison of the efficiency of rose bengal and methylene blue as photosensitizers in photodynamic therapy techniques for Enterococcus faecallis inactivation. Photomed Laser Surg. 2017;35(1).
58 - CARNEIRO VSM, ARAÚJO NC, MENEZES RF, MORENO LM, SANTOS- NETO AP, GERBI MEM. Effect of low-level laser therapy on the fungal proliferation of Candida albicans. Proc of SPIE. 2016;9695.
59 - RODRIGUES ME, SILVA S, AZEREDO J, HENRIQUES M. Novel strategies to fight Candida species infection. Crit Rev Microbiol. 2016;42(4):594-606.
60 - ROSA LP, SILVA FC, VIANA MS, MEIRA GA. In vitro effectiveness of 455-nm blue LED to reduce the load of Staphylococcus aureus and Candida albicans biofilms in compact bone tissue. Lasers Med Sci. 2016;31(1):27-32.
61 - LU C, FAN Z, XING D. Photo-enhancement of macrophage phagocytic activity via Rac1-mediated signaling pathway: Implications for bacterial infection. Int J Biochem Cell Biol. 2016 Sep;78:206-216.
62 - DOLMANS DEJGJ, FUKUMURA D, JAIN RK. Photodynamic therapy for cancer.
Nature. 2003;3(5):380-387.
63 - AGOSTINIS P, BERG K, CENGEL KA, FOSTER TH, GIROTTI AW, GOLLNICK SO, HAHN SM, HAMBLIN MR, JUZENIENE A, KESSEL D, KORBELIK M, MOAN J, MROZ P, NOWIS D, PIETTE J, WILSON BC, GOTAB J.
Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250-281.
64 - WAINWRIGHT M, MAISCH T, NONELL S, PLAETZER K, ALMEIDA A, TEGOS GP, HAMBLIN MR. Photoantimicrobials - are we afraid of the light?. Lancet Infect Dis. 2017;17(2):49-55.
65 - BIEL MA. Photodynamic therapy of bacterial and fungal biofilm infections.
Methods Mol Biol. 2010;635:175-94.
66 - SAINI R, LEE NV, LIU KYP, POH CF. Prospects in the application of photodynamic therapy in oral cancer and premalignant lesions. Cancers. 2016;8(9):83.
67 - ASPIROZ C, SEVIL M, TOYASC C, GILABERTED Y. Photodynamic Therapy With Methylene Blue for Skin Ulcers Infected With Pseudomonas aeruginosa and Fusarium spp. Actas Dermosifiliogr. 2017;108(6):e45-e48.
68 - CAIRES CSA, LEAL CRB, RAMOS CAN, BOGO D, LIMA AR, ARRUDA EJ, OLIVEIRA SL, CAIREIS ARL, NASCIMENTO VA. Photoinactivation effect of eosin methylene blue and chlorophyllin sodium-copper against Staphylococcus aureus and Escherichia coli. Lasers Med Sci. 2017;32(5):1081-1088.
69 - PÉREZ-LAGINA V, PÉREZ-ARTIAGA L, LAMPAYA-PÉREZ V, GARCÍA- LUQUE I, BALESTA S, NONELL S, PAZ-CRISTOBAL MP, GILABERTE Y, REZUSTA A. Bactericidal effect of photodynamic therapy, alone or in combination with mupirocin or linezolid, on Staphylococcus aureus. Front Microbiol. 2017;8:1002.
70 - CARVALHO DPL, PINTO JG, SORGE CPC, BENEDITO FRR, KHOURI S, STRIXINO JF. Study of photodynamic therapy in the control of isolated microorganisms from infected wounds—an in vitro study. Lasers Med Sci.
2014;29(1):113-20.
71 - ROSA LP, DA SILVA FC, NADER SA, MEIRA GA, VIANA MS. Antimicrobial photodynamic inactivation of Staphylococcus aureus biofilms in bone specimens using methylene blue, toluidine blue ortho and malachite green: An in vitro study. Arch Oral Biol. 2015;60(5):675-80.
72 - FILA G, KASIMOVA K, ARENAS Y, NAKANIECZNA J, GRINHOLC M, BIELAWSKI KP, LILGE L. Murine model imitating chronic wound for evaluation of antimicrobial photodynamic therapy efficacy. Front Microbiol. 2016;7:1258.
73 - CHUI C, HIRATSUKA K, AOKI A, TAKEUCHI Y, ABIKO Y, IZUMI Y. Blue LED inhibits the growth of Porphyromonas gingivalis by suppressing the expression of genes associated with DNA replication and cell division. Lasers Surg Med.
2012;44:856-864.
74 - DE LUCCA AJ, CARTER-WIENTJES C, WILLIAMS KA, BHATNAGAR D.
Blue light (470 nm) effectively inhibits bacterial and fungal growth. Lett Appl Microbiol. 2012;55:460-6.
75 - DAI T, GUPTA A, HUANG YY, SHERWOOD ME, MURRAY CK, VRAHAS MS, KIELIAN T, HAMBLIN MR. Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg. 2013;31(11):531-8.
76 - GUFFEY JS, PAYNE W, JONES T, MARTIN K. Evidence of resistance development by Staphylococcus aureus to an in vitro, multiple stage application of 405 nm light from a supraluminous diodo array. Photomed Laser Surg. 2013;31(4):179-182.
77 - PILEGGI G, WATAHA JC, GIRARD M, GRAD I, SCHRENZEL J, LANGE N, BOUILLAGUET S. Blue light-mediated inactvation of Enterococcus faecalies in vitro.
Photodiagnosis Photodyn Ther. 2013;10:134-140.
78 - MASSON-MEYERS DS, BUMAH VV, BIENER G, RAICU V, ENWEMEKA CS. The relative antimicrobial effect of blue 405 nm LED and blue 405 nm laser on methicillin-resistant Staphylococcus aureus in vitro. Lasers Med Sci. 2015;30(9):2265- 71.
79 - CHEBATH-TAUB D, STEINBERG D, FEATHERSTONE JD, FEUERSTEIN O.
Influence of blue light on Streptococcus mutans re-organization in biofilm. J Photochem Photobiol B. 2012; 116:75-8.
80 - COHEN-BERNERON J, STEINBERG D, FEATHERSTONE JD, FEUERSTEIN O. Sustained effects of blue light on Streptococcus mutans in regrown biofilm. Lasers Med Sci. 2016;31:445–452.
81 - LIPOVSKY A, NITZAN Y, GEDANKEN A, LUBART R. Visible light-induced killing of bacteria as a function of wavelength: implication for wound healing. Lasers Med Sci. 2010;42:467-472.
82 - ZHANG Y, ZHU Y, GUPTA A, HUANG Y, MURRAY CK, VRAHAS MS, SHERWOOD ME, BAER DG, HAMBLIN MR, DAI T. Antimicrobial blue light therapy for multidrug-resistant Acinetobacter baumannii infection in a mouse burn model: implications for prophylaxis and treatment of combat-related wound infections.
J Infect Dis. 2014;209:1963-71.
83 - KUSHIBIKI T, HIRASAWA T, OKAWA S, ISHIHARA M. Blue laser irradiation generates intracellular reactive oxygen species in various types of cells. Photomed Laser Surg. 2013;31(3):95-104.
84 - BUMAH VV, MASSON-MEYERS DS, ENWEMEKA CS. Blue 470 nm light suppresses the growth of Salmonella enterica and methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med. 2015;47:595–601.
85 - FEUERSTEIN O. Light therapy: complementary antibacterial treatment of oral biofilm. Adv Dent Res. 2012;24(2):103-107.
86 - KAWADA A, ARAGANE Y, KAMEYAMA H, SANGEN Y, TEZUKA T. Acne phototherapy with a high-intensity, enhanced, narrowband, blue light source: an open study and in vitro investigation. J Dermatol Sci. 2002;30:129-135.
87 - DAI T, GUPTA A, HUANG YY, YIN R, MURRAY CK, VRAHAS MS, SHERWOOD ME, TEGOS GP, HAMBLIN MR. Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety and mechanism of action. Antimicrob Agents Chemother. 2013;57(3):1238–1245.
88 - SCHNEDEKER AH, COLE LK, LORCH G, DIAZ SF, BONAGURA J, DANIELS JB. In vitro bactericidal activity of blue light (465 nm) phototherapy on meticillin-susceptible and meticillinresistant Staphylococcus pseudintermedius. Vet Dermatol 2017;28(5):463-e106.
89 - ADAIR T, DRUM BE. RNA-Seq reveals changes in the Staphylococcus aureus transcriptome following blue light illumination. Genom Data. 2016;9:4–6.
90 - BIENER G, MASSON-MEYERS DS, BUMAH VV, HUSSEY G, STONEMAN MR, ENWEMEKA CS, RAICU V. Blue/violet laser inactivates methicillin-resistant Staphylococcus aureus by altering its transmembrane potential. J Photochem Photobiol B. 2017;170:118-124.
91 - SHEN J, STEINBACH R, TOBIN JM, NAKATA MM, BOWER M, MCCOUSTRA MRS, BRIDLE H, ARRIGHI V, VILELA F. Photoactive and metal- free polyamide-based polymers for water and wastewater treatment under visible light irradiation. Appl Catal B. 2016;193:226-233.
92 - BUSHNELL GW, LOUIE GV, BRAYER GD. High-resolution three-dimensional structure of horse heart cytochrome c. J Mol Biol. 1990;214(2):585-95.
93 - KRAFT ML. Plasma Membrane Organization and Function. 1999. Disponível em:
http://www.scs.illinois.edu/~mlkraft/Kraft_group_research-2.html. Acesso em: 10 de Julho de 2018 às 19:22.
94 - BUMAH VV, WHELAN HT, MASSON-MEYERS DS, QUIRK B, BUCHMANN E, ENWEMEKA CS. The bactericidal effect of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus (MRSA). Lasers Med Sci. 2015;30:1153–
1159.
95 - YANG P, WANG N, WANG C, YAO Y, FU X, YU W, CAI R, YAO M. 460 nm visible light irradiation eradicates MRSA via inducing prophage activation. J Photochem Photobiol B. 2017;166:311–322.
96 - BAFFONI M, BESSA LJ, GRANDE R, GIULIO MD, MONGELLI M, CIARELLI A, CELLINI L. Laser irradiation effect on Staphylococcus aureus and Pseudomonas aeruginosa biofilms isolated from venous leg ulcer. Int Wound J. 2012;9:517-24.
97 - CHUNG W, PETROFSKY JS, LAYMON M, LOGOLUSO J, PARK J, LEE J, LEE H. The effects of low level laser radiation on bacterial growth. Phys Ther Rehabil Sci. 2014;3(1):20-6.
98 - ENWEMEKA CS, WILLIAMS D, HOLLOSI S, YENS D, ENWEMEKA SK.
Visible 405 nm SLD light photo-destroys methicillin-resistant Staphylococcus aureus (MRSA) in vitro. Lasers Surg Med. 2008;40:734–737.
99 - ENWEMEKA CS. Antimicrobial blue light: an emerging alternative to antibiotics.
Photomed Laser Surg. 2013;31(11):509-511.
100 - GUFFEY JS, WILBORN J. In vitro bactericidal effects of 405-nm and 470-nm blue light. Photomed Laser Surg. 2006;24(6):684-688.
101 - HALSTED FD, THWAITE JE, BURT R, LAWS TR, RAGUSE M, MOELLER R, WEBBER MA, OPPENHEIM BA. The antibacterial activity of blue light against nosocomial wound pathogens growing planktonically and as mature biofilms. Appl Environ Microbiol. 2016;82(13):4006-4016.
102 - MACLEAN M, MACGREGOR SJ, ANDERSON JG, WOOLSEY G. High- intensity narrow-spectrum light inactivation and wavelength sensitivity of Staphylococcus aureus. FEMS Microbiol Lett. 2008;285:227–232.